Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.401
-0.190 (-7.32%)
Mar 31, 2025, 1:24 PM EDT - Market open
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $2.90 million as of March 31, 2025. Its market cap has decreased by -42.09% in one year.
Market Cap
2.90M
Enterprise Value
993.84K
1-Year Change
-42.09%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since the IPO on December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from $32.74M to $2.90M, a decrease of -91.14%. That is a compound annual growth rate of -65.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 3.13M | -15.08% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -45.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |